Journal articleInvest New Drugs2018
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma.
- Journal
- Invest New Drugs
- Published
- 8 November 2017
- Citations
- 177
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- Builds on itStudy of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) NCT02331251↗
- BackgroundSintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer NCT06050317↗
- BackgroundNivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer NCT04377048↗